Endologix, Inc. (ELGX) financial statements (2022 and earlier)

Company profile

Business Address 2 MUSICK
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18,496 41,56046,58750,9439,696
Cash and cash equivalents18,496 41,56046,58750,9439,696
Restricted cash and investments1,200 1,2001,2001,2001,200
Receivables11,362 22,67421,88722,25826,328
Inventory, net of allowances, customer advances and progress billings25,908 26,40530,87730,74730,202
Inventory25,908 26,40530,87730,74730,202
Other current assets4,441 1,8642,0582,2702,535
Total current assets:61,407 93,703102,609107,41869,961
Noncurrent Assets
Operating lease, right-of-use asset5,644 5,7685,6605,728 
Property, plant and equipment11,838 13,15213,69114,49515,236
Intangible assets, net (including goodwill)191,864 193,417194,264195,278196,117
Goodwill120,816 120,814120,770120,837120,815
Intangible assets, net (excluding goodwill)71,048 72,60373,49474,44175,302
Other noncurrent assets662 1,1241,2931,3722,392
Other undisclosed noncurrent assets     5,787
Total noncurrent assets:210,008 213,461214,908216,873219,532
TOTAL ASSETS:271,415 307,164317,517324,291289,493
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities36,911 45,18746,30242,53144,153
Accounts payable8,837 14,02411,77912,45414,923
Accrued liabilities15,084 12,93115,79116,24116,057
Employee-related liabilities12,990 18,23218,73213,83613,173
Debt192,687     
Other undisclosed current liabilities  10,606   
Total current liabilities:229,598 55,79346,30242,53144,153
Noncurrent Liabilities
Long-term debt and lease obligation11,127 183,681176,993165,024203,482
Long-term debt, excluding current maturities  172,060176,993165,024203,482
Operating lease, liability11,127 11,621   
Liabilities, other than long-term debt2,273 2,89415,32516,58816,293
Accounts payable and accrued liabilities   11,64011,81211,976
Deferred income tax liabilities150 150150150 
Other liabilities1,823 2,2442,2352,3262,317
Business combination, contingent consideration, liability300 5001,3002,3002,000
Other undisclosed noncurrent liabilities  9409,11228,0726,185
Total noncurrent liabilities:13,400 187,515201,430209,684225,960
Total liabilities:242,998 243,308247,732252,215270,113
Stockholders' equity
Stockholders' equity attributable to parent28,417 63,85669,78572,07619,380
Common stock19 18181710
Treasury stock, value(4,278) (4,235)(4,154)(4,120)(4,027)
Additional paid in capital738,571 730,729728,094722,478643,150
Accumulated other comprehensive income2,786 1,8162,4692,5781,990
Accumulated deficit(708,681) (664,472)(656,642)(648,877)(621,743)
Total stockholders' equity:28,417 63,85669,78572,07619,380
TOTAL LIABILITIES AND EQUITY:271,415 307,164317,517324,291289,493

Income statement (P&L) ($ in thousands)

6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Revenues24,841 35,75135,77536,23835,606
Cost of revenue
(Cost of Goods and Services Sold)
(10,688) (13,922)(12,701)(13,254)(12,407)
Gross profit:14,153 21,82923,07422,98423,199
Operating expenses(31,502) (31,687)(33,904)(32,851)(35,193)
Operating loss:(17,349) (9,858)(10,830)(9,867)(11,994)
Nonoperating income (expense)(8,698) 7982,784(20,520)(9,995)
Interest and debt expense(10,863)  (8,527)(11,756)(8,490)
Other undisclosed income from continuing operations before equity method investments, income taxes10,863  8,52711,7568,490
Loss from continuing operations before income taxes:(26,047) (9,060)(8,046)(30,387)(21,989)
Income tax expense (benefit)(46) 1,2302813,253(39)
Net loss available to common stockholders, diluted:(26,093) (7,830)(7,765)(27,134)(22,028)

Comprehensive Income ($ in thousands)

6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
Net loss:(26,093) (7,830)(7,765)(27,134)(22,028)
Other comprehensive income (loss)222  (109)588 
Comprehensive loss:(25,871) (7,830)(7,874)(26,546)(22,028)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (653)  (598)
Comprehensive loss, net of tax, attributable to parent:(25,871) (8,483)(7,874)(26,546)(22,626)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: